Sleep Disorder Connect
  • Saved
The validity and reliability of the Japanese version of RU-SATED

The validity and reliability of the Japanese version of RU-SATED

Source : https://www.sciencedirect.com/science/article/abs/pii/S1389945722000582?via=ihub

We developed a Japanese version of RU-SATED for measuring sleep health. * The reliability of the scale was examined and found to be sufficiently high. * The results of the...


Conclusion: The RU-SATED is a promising new instrument for measuring multi-dimensional sleep health perception among Japanese adults. Further general population studies using this Japanese version of the questionnaire should be considered.

  • 4yr
    RU-SATED is a promising new instrument for measuring multi-dimensional sleep health perception among Japanese adults
  • 4yr
    Key Points • Source: Sleep Medicine • Conclusion: “The RU-SATED is a promising new instrument for measuring multi-dimensional sleep health perception among Japanese adults. Further general population studies using this Japanese version of the Show More
  • Saved
Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors

Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors

Source : https://www.sciencedirect.com/science/article/abs/pii/S1087079222000284?via=ihub

This systematic review and meta-analysis assessed the efficacy of cognitive-behavioural therapy for insomnia (CBT-I) among cancer survivors and explored its effect on comorbid symptoms. Studies were included if they assessed...


Conclusion/Relevance: Overall, CBT-I is a robustly efficacious and durable treatment for insomnia among cancer survivors and can produce concomitant benefits on other symptoms. Implementation efforts are needed to ensure that people with cancer have access to CBT-I as the recommended first-line treatment for insomnia.

  • Saved
Daridorexant: First Approval - PubMed

Daridorexant: First Approval - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35298826/

Daridorexant (Quviviq™; Idorsia Pharmaceuticals Ltd.) is an orally administered dual orexin type 1 and type 2 (OX 1 and OX 2 ) receptor antagonist (DORA) being developed for the treatment...


Conclusion/Relevance: This article summarizes the milestones in the development of daridorexant leading to this first approval.

  • Saved
Is the sodium in sodium oxybate a risk for heart health? A plain language summary of publication - PubMed

Is the sodium in sodium oxybate a risk for heart health? A plain language summary of publication - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35244452/

This suggests that the sodium in sodium oxybate may not add cardiovascular risk for people with narcolepsy. People currently taking sodium oxybate should talk to their doctor to ask if...


Relevance: This suggests that the sodium in sodium oxybate may not add cardiovascular risk for people with narcolepsy. People currently taking sodium oxybate should talk to their doctor to ask if they need to be concerned about the sodium in their medicine. People who take sodium oxybate are unlikely to need to change their sodium oxybate...

  • Saved


Conclusions and Relevance: This qualitative study found that REMS programs with ETASU reassured patients and their caregivers about drug safety and helped support medication initiation. However, steps are needed to improve the quality of REMS educational materials, promote efficient medication access, and protect patient privacy.